Shuyue Sheng

发表

miR-23a-3p regulates the inflammatory response and fibrosis in diabetic kidney disease by targeting early growth response 1

Yaoming Xue, Shuyue Sheng, Meina Zou, 2021, In Vitro Cellular & Developmental Biology - Animal.

26-LB: Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter, Randomized, Parallel Study

Huijie Zhang, M. Zou, Yaoming Xue, 2020, Diabetes.

High-Salt Attenuates the Efficacy of Dapagliflozin in Tubular Protection by Impairing Fatty Acid Metabolism in Diabetic Kidney Disease

Shuyue Sheng, Meina Zou, Meiping Guan, 2021, Frontiers in Pharmacology.

Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease

Huijie Zhang, M. Zou, Shuyue Sheng, 2020, American Journal of Nephrology.